The purpose of this study is to evaluate the safety and tolerability of BMS-986553, CD19 in vivo Chimeric Antigen Receptor (CAR) T cells, in participants with …

Systemic Lupus ErythematosusSjögren's DiseaseRheumatoid Arthritis+3 more

~Estimated

~$150 – $4,500

Actual pay is set by the research site.

Bristol-Myers SquibbNCT07873931

Phase 2

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2a/b Study Assessing the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

To evaluate efficacy, safety, and tolerability of DDY391 up to 52 weeks in participants with Sjögren's disease (SjD) and to determine the dose response relatio…

Sjögren's Disease

~Estimated

~$75 – $2,800

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07737743